VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission.
A complete response with combination chemotherapy was obtained in a patient with metastatic Merkel cell carcinoma. This complete response lasted 15 months. This case report demonstrates the chemosensitivity of this metastatic disease when treated with combination chemotherapy.
Azagury
M
M
Medical Oncology Service, Centre H. Becquerel, Rouen, France.
Chevallier
B
B
Atlan
D
D
Graic
Y
Y
Dayot
J P
JP
Thomine
E
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D015266:Carcinoma, Merkel Cell / Q000188:drug therapy* / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy*
D001761:Bleomycin; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin